Video Library
The specially recorded sessions (mainly from the WPA Action Plan Groups) will be available to view, at your leisure, from the day the hybrid platform opens and for 3 months after the congress.
All recorded sessions will be included in the registration fees, for both onsite and online participants.
Stay tuned to this page!
Psychiatry Worldwide – Spanish Session – Psicofarmacología y embarazo & Actualización en estabilizadores del ánimo
Chair: Santiago Levin, Argentina
-Psicofarmacología y embarazo
Laura Lorenzo, Argentina
-Actualización en estabilizadores del ánimo
Danilo Quiroz, Chile
Psychiatry Worldwide – Spanish Session – Mejorando el apego en la esquizofrenia con antipsicóticos de depósito & Bipolar disorder and long lasting antipsychotic medication
Chair: Bernardo Ng, Mexico/USA
-Mejorando el apego en la esquizofrenia con antipsicóticos de depósito
Hugo Castellanos, México
-Bipolar disorder and long lasting antipsychotic medication
Mauricio Tohen, México
Psychiatry Worldwide – Spanish Session – Depresion resistente vs depresión refractaria a tratamiento & Abordaje farmacológico de la depresión resistente
Chair: Thelma Sanchez, México
-Depresion resistente o depresion sub estudiada?
Ricardo Millan, Costa Rica
-Abordaje farmacológico de la depresión resistente
Bernardo Ng, México/USA
Psychiatry Worldwide – Spanish Session – Una mirada al manejo integral del paciente con esquizofrenia & Consideraciones sobre el manejo farmacológico del paciente mayor
Chair: Rodrigo Córdoba, Colombia
-Una mirada al manejo integral del paciente con esquizofrenia
Enrique Bojórquez, Perú
-Consideraciones sobre el manejo farmacológico del paciente mayor
Jose Manuel Santacruz, Colombia
Psychiatry Worldwide, Speaking French: Update on the role of psychopharmacology in Child and Adolescent psychiatry / Actualité sur la place de la psychopharmacologie en psychiatrie de l enfant et de l adolescent
Chair: Michel Botbol, France
– La psychopharmacologie au carrefour de contraintes spécifiques en psychiatrie de l enfant et de l’adolescent – Psychopharmacology in Child and Adolescent Psychiatry at the crossroad of specific constraints
Michel Botbol, France
– Le TDAH, pathologie illustrative de la place de la psychopharmacology en psychiatrie de l enfant – ADHD an illustrative pathology of the place of psychopharmacology in child psychiatry
Cedric Galer, France
– Nouvelles sur les perspectives de traitement pharmacologique dans les TSA et sur l’utilisation de substances psychédéliques en psychiatrie de l enfant et de l adolescent – News on the prospects for drug treatment in ASD and on the use of psychedelic molecules in child and adolescent psychiatry
Olivier Bonnot, France
Updates on treatment – related issues: Research on Asian Psychotropic Prescription Pattern (RAEP): Lessons learned from REAP studies over 20 years
Chair: Chay Hoon Tan, Singapore
-The REAP project: from psychotropic prescriptions to adverse events and psychopathology
Yu Tao Xiang, Macau
-Analysis of the trends of polypharmacy and high-dose prescriptions in Japan-Importance of social and economic factors
Naotaka Shinfuku, Japan
-Has the spectrum of adverse drug effects changed with the popularized use of the second generation antipsychotics? Evidence from Asian countries
Chay-Hoon Tan, Singapore
Updates on treatment – related issues: Research on Asian Psychotropic Prescription Pattern (RAEP): Challenges of REAP studies in coming years
Chair: Takahiro A. Kato, Japan
-Using network analysis for data from the REAP Survey
Seon-Cheol Park, Korea
-Racial differences in the pharmacokinetics of psychotropic drugs
Shi-ku Lin, Taiwan
-Considering appropriate prescribing actions based on the findings of REAP study
Takahiro A. Kato, Japan
Updates on treatment – related issues: Schizophrenia, depression, psychosomatic: principles of psychopharmacotherapy (Session in Russian)
-Therapy of depression
Galina Mazo, Russia
Updates on treatment – related issues: Update on vascular cognitive impairment and lewy body dementia
Chair: E Mohandas, India
-Vascular cognitive impairment – Conceptual evolution and clinical diagnosis
Ramalingam Chithiramohan, UK
-Update on lewy body dementia
Shabbir Amanullah, Canada
Other issues: Social determinants of mental health and the treatment of mental disorders
Chair: Allan Tasman, USA
-Clinical assessment of social determinants of mental health to improve treatment outcomes
Allan Tasman, USA
-Addressing the impact of social determinants of mental health: Enhancing clinical care and building community support programs
Kenneth Thompson, USA
Action plan: Global mental health and rights of persons with intellectual and developmental disabilities
Chair: Kerim Munir, USA
–Position statement on intellectual disability/intellectual developmental disorders: The need for a second paradigm change
Kerim Munir, USA
-Adapting the UN Convention on the rights of persons with disabilities and the question of mental health, disability and human rights, to the WPA Statement
Michael Stein, USA
-How can mental health be a global change agent for improved outcomes and human rights at grass roots in the care of persons with IDD?
Ashok Roy, UK
Action plan: Early interventions in mental health
-Swaran Singh, UK
-Srividya Iyer, Canada
Action plan: Promoting psychiatry among medical students
Chair: Nazish Imran
-21st Century Recruitment: The crucial role of social media for medical students engagement in psychiatry
Howard Y. Liu, USA
-Reducing stigma towards psychiatry among medical students
Nazish Imran, Pakistan
-Initiatives of WPA medical students working group in promoting psychiatry among medical students
Muhammad Waqar Azeem, Qatar
Action plan: WHO Mental Health Gap Programme: Supporting work of psychiatrists in mental health care
The case for mental health gap guidelines
Jonathan Campion, UK
WHO mhGAP Principles of use and field examples
Peter Hughes, UK
Implementing mhGAP guidelines -challenges and opportunities
Asma Humayan, UK
Action plan: Public mental health
Public mental health: an overview of a WPA priority area
Jonathan Campion, UK
Public mental health: making the case of investment, practice and training
Crick Lund, South Africa
Public mental health: organising and delivering services more effectively
Shekhar Saxena, USA
Action plan: Together we are stronger: Recovery, trialogue and a human rights-based approach to mental health care
Chair: Guadalupe Morales/Spain
– Human Rights: First! Nothing about us, without us
Guadalupe Morales, Spain
– Through the eyes of a mother: let’s work together to replace coercion with respect
Martha Savage, New Zealand
-Mental health trialogue – Evidence, experience, ethics
Michaela Amering, Austria
Action plan: Importance of psychiatry in graduate medical education and as a career
Chair: Pronob K. Dalal, India
-Promoting psychiatry around the World: The production of a video
Bernardo Ng, USA
-COVID-19 and impact on medical students education in University of Ottawa, Canada
Khalid Bazaid, Canada
-The new Indian medical graduate program in psychiatry
Pronob K. Dalal, India
Action plan: COVID care for people with mental illness
Chair: Wendy Burn, UK
-Care for people with mental illness during the COVID-19 pandemic: lessons learnt from around the world
Wendy Burn, UK
-Neuropsychiatric effects of COVID-19 infection
Paul Summergrad, USA
-The impact of COVID-19 on mental health in LMICs: the example of Tunisia
Uta Ouali, Tunisia
Action plan: Early Intervention in LMICs: lessons learnt so far
Opening remarks and lessons from WIC
Swaran Singh, UK
– School-based early intervention strategies
R Thara, India
– Early detection through collaboration with faith healers
Jibril Abdulmalik, Nigeria
– The role of family in early psychosis: an LMIC perspective
Srividya Iyer, Canada
Action plan: prevalence and presentation of psychopathological issues in persons with ASD and cognitive/communication difficulties
Chair: Marco O. Bertelli, Italy
– The blurred boundaries between autism spectrum disorders and intellectual disabilities
Kerim Munir, USA
– Problem behaviors and psychopathology: a controversial relationship
Marco O. Bertelli, Italy
– Reorganising services for mental health of persons with ASD and ID: the Italian experience
Maria Luisa Scattoni, Italy
New drug treatments in psychiatry
Chair: Kostas Fountoulakis, Greece
-Novel drug treatments for schizophrenia
Eva-Maria Tsapakis, Greece
-Ketamine, Psychedelics and Neuroplasticity in Mood Disorders
Gregor Hasler, Switzerland
-Novel treatments in Bipolar Disorder
Dina Popovic, Israel
-Advances in the treatment of alcohol use disorder: an update
Ming-Chyi Huang, Taiwan
Telepsychiatry: competencies and challenges
Davor Mucic:
1. Historical review of TP
2. Patients´ and professionals` attitudes toward TP
3. Advantages and disadvantages of home-based and institution-based TP
Donald Hilty:
1. TMH evidence and practice (evaluation, triage and treatment).
2. TP´ impact on therapeutic relationship
3. Clinical: assessment of the approach and outcome of TP
Jay Shore:
1. Setting up a standardized TP service (equipment, the room, development of a
protocol, ethical considerations; specific populations and settings i.e. clinically
supervised vs unsupervised settings, primary care settings, inpatient facilities,
facilities specialized in dealing with problems related to substance abuse, geriatric
and other facilities)
Donald Hilty and Davor Mucic:
1. Specific domains of TP competency: adjustment of communication
arrangements to help clinicians engage, develop and enhance the doctor-patient
therapeutic relationship
2. Pre-session preparation and “framing”.
3. Legal and regulatory issues: informed consent, privacy, and confidentiality.
4. Getting started with patients: adjusting personal and professional styles
5. Cultural, geographic and international themes
Reducing mental illness stigma: Evidence and experience
Chair: Nicolas Rüsch, Germany
Part 1:
-Changing Geographies of Stigma following Deinstitutionalization
Egle Sumskiene, Lithuania
-Fighting Stigma in Developing Countries
Mrugesh Vaishnav, India
-Key Strategies for Fostering Internalized Stigma Resistance
Alicia Lucksted, USA
-Addressing Stigma on College Campuses
Bernice Pescosolido, USA
Roundtable Discussion (25 min)
Break (10 minutes)
Part 2
-Best Principles and Practices in Anti-stigma Programming
Heather Stuart, Canada
-Scales to Assess Stigma and Discrimination in Many Languages
Graham Thornicroft, UK
-Roundtable Discussion (30 min)
-Closing Remarks
Nicolas Rüsch, Germany
Physical illnesses in patients with severe mental disorders: Current challenges and practical implications for professionals
Chair: Andrea Fiorillio, Italy
-Opening and introduction
Afzal Javed, UK (President World Psychiatric Association)
-The complex interplay between physical and mental disorders: clinical, social and practical implications for mental health professionals
Mohan Isaac, Australia
-The scandal of premature mortality: what is the role of stigma in improving the physical health of people with severe mental illness
Graham Thornicroft, UK
The relationship between diabetes and depressive disorder
Elena Starostina, Russia
Organisation of health services for people with comorbid mental and physical disorders
Andrea Fiorillo, Italy
-Interactive discussion based on the presentation of practical experiences in the
management of physical illness in people with severe mental disorders
Mariana Pinto da Costa, UK
-Conclusions and outlook
Norman Sartorius, Switzerland
Basic principles of cognitive therapy
Roger Ng, China
-Ahmed Okasha, Egypt – The need for empathy and action
-Rajiv Tandon, USA – Diagnostic guidelines. DSM5, ICD11 and beyond
-Miro Jakovljevic, Croatia – Psychiatry for a better world: Culture of empathy and mental health promotion
-Cathy Lloyd, UK – Diabetes and depression: the development and findings of the Interpret DD International study on diabetes and depression
Marco Solmi, Italy & Christoph Correll, USA – The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT): design, validation, and preliminary results